Branden Wolner, PhD

Scientific Advisor

Dr. Wolner is a Biotechnology/Biopharma research innovator and leader. He has led the development of novel recombination-based technologies for gene replacement projects, strain improvement efforts for advanced cellulosic biofuel production and the overhaul several high throughput screening and metabolic engineering groups. He provides scientific analysis and advice on a myriad of business development opportunities and operates the consulting group Recombine Technologies (www.rDNAtechnologies.com)

Interested in investing?

Contact us to learn more about our investments and the benefits of partnering with us.